Pacer Advisors, Inc. Sorrento Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$6.35 - $10.0 $48,298 - $76,060	-7,606 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$7.03 - $16.51 $67,516 - $158,562	-9,604 Reduced 55.8%	7,606 $63,000
Q4 2020 Jan 20, 2021	BUY	$5.76 - $11.95 $22,487 - $46,652	3,904 Added 29.34%	17,210 $117,000
Q3 2020 Oct 19, 2020	BUY	$6.17 - $18.82 $82,098 - $250,418	13,306 New	13,306 $148,000
Q4 2018 Feb 13, 2019	SELL	$2.01 - $4.24 $42,957 - $90,617	-21,372 Closed	0 $0

Q3 2018 Nov 14, 2018	BUY	$4.22 - $7.5 $90,189 - $160,290	21,372 New	21,372 $94,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.